Rationale and design of the cardiovascular status in patients with endogenous cortisol excess study (CV-CORT-EX): a prospective non-interventional follow-up study

被引:5
|
作者
Ehrlich, Kristina [1 ]
Morbach, Caroline [2 ,3 ,4 ,5 ]
Reiter, Theresa [2 ]
Heuschmann, Peter Ulrich [6 ,7 ]
Hannemann, Anke [8 ,9 ]
Fassnacht, Martin [1 ,3 ,4 ]
Stoerk, Stefan [2 ,3 ,4 ]
Hahner, Stefanie [1 ]
Deutschbein, Timo [1 ,10 ]
机构
[1] Univ Wurzburg, Univ Hosp Wurzburg, Div Endocrinol & Diabet, Dept Internal Med 1, Oberdurrbacher Str 6, D-97080 Wurzburg, Germany
[2] Univ Wurzburg, Univ Hosp Wurzburg, Div Cardiol, Dept Internal Med 1, Wurzburg, Germany
[3] Univ Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany
[4] Univ Wurzburg, Univ Hosp Wurzburg, Wurzburg, Germany
[5] Univ Wurzburg, Univ Hosp Wurzburg, Acad Core Lab Ultrasound Based Cardiovasc Imaging, Wurzburg, Germany
[6] Univ Wurzburg, Univ Hosp Wurzburg, Clin Trial Ctr, Wurzburg, Germany
[7] Univ Wurzburg, Inst Clin Epidemiol & Biometry, Wurzburg, Germany
[8] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany
[9] Univ Med Greifswald, Partner Site Greifswald, German Ctr Cardiovasc Res DZHK, Greifswald, Germany
[10] Medicover Oldenburg MVZ, Oldenburg, Germany
关键词
Cardiac magnetic resonance imaging; Cardiovascular status; Cushing's syndrome; Echocardiography; Endogenous; Glucocorticoid excess; Hormones; Left ventricular hypertrophy; Metabolic profile; Quality of life; QUALITY-OF-LIFE; CORONARY-ARTERY-DISEASE; CUSHINGS-SYNDROME; RISK-FACTORS; ACTIVE DISEASE; MORTALITY; HEALTH; ATHEROSCLEROSIS; ECHOCARDIOGRAPHY; PERSISTENCE;
D O I
10.1186/s12902-020-00665-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Endogenous Cushing's syndrome (CS) results in increased cardiovascular (CV) morbidity and mortality. So far, most studies focussed on distinct disease entities rather than the integrity of the CV system. We here describe the design of the Cardiovascular Status in Endogenous Cortisol Excess Study (CV-CORT-EX), a study aiming to comprehensively investigate the health status of patients with endogenous CS (with a particular focus on CV phenotypes, biochemical aspects, quality of life, and psychosocial status). Method: A prospective non-interventional cohort study performed at a German tertiary referral centre. At the time of enrolment, patients will be categorised as: (1) newly diagnosed overt CS, (2) recurrent overt CS, (3) CS in remission, (4) presence of mild autonomous cortisol excess (MACE). The target cohorts will be n = 40 (groups 1 + 2), n = 80 (group 3), and n = 20 (group 4). Patients with overt CS at the time of enrolment will be followed for 12 months after remission (with re-evaluations after 6 and 12 months). At each visit, patients will undergo transthoracic echocardiography, cardiac magnetic resonance imaging, 24-h electrocardiogram, 24-h blood pressure measurement, and indirect evaluation of endothelial function. Furthermore, a standardised clinical investigation, an extensive biochemical workup, and a detailed assessment of quality of life and psychosocial status will be applied. Study results (e.g. cardiac morphology and function according to transthoracic echocardiography and cardiac magnetic resonance imaging; e.g. prevalence of CV risk factors) from patients with CS will be compared with matched controls without CS derived from two German population-based studies. Discussion: CV-CORT-EX is designed to provide a comprehensive overview of the health status of patients with endogenous CS, mainly focussing on CV aspects, and the holistic changes following remission.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Rationale and design of the cardiovascular status in patients with endogenous cortisol excess study (CV-CORT-EX): a prospective non-interventional follow-up study
    Kristina Ehrlich
    Caroline Morbach
    Theresa Reiter
    Peter Ulrich Heuschmann
    Anke Hannemann
    Martin Fassnacht
    Stefan Störk
    Stefanie Hahner
    Timo Deutschbein
    BMC Endocrine Disorders, 21
  • [2] Cardiovascular status in endogenous cortisol excess: the prospective CV-CORT-EX study
    Morbach, Caroline
    Detomas, Mario
    Sahiti, Floran
    Hoffmann, Kristina
    Kroiss, Matthias
    Gelbrich, Goetz
    Frantz, Stefan
    Hahner, Stefanie
    Heuschmann, Peter Ulrich
    Fassnacht, Martin
    Stoerk, Stefan
    Deutschbein, Timo
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2024, 191 (06) : 604 - 613
  • [3] Rationale and design of ON TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib
    Yang, James C. H.
    Brose, Marcia S.
    Castro, Gilberto
    Kim, Edward S.
    Lassen, Ulrik N.
    Leyvraz, Serge
    Pappo, Alberto
    Lopez-Rios, Fernando
    Reeves, John A.
    Fellous, Marc
    Penault-Llorca, Frederique
    Rudzinski, Erin R.
    Tabatabai, Ghazaleh
    Vassal, Gilles
    Drilon, Alexander
    Trent, Jonathan
    BMC CANCER, 2022, 22 (01)
  • [4] DESIGN AND RATIONALE OF THE MULTIPLE MYELOMA PREAMBLE STUDY: A PROSPECTIVE, NON-INTERVENTIONAL, MULTI-CENTER COHORT STUDY
    Zhang, B.
    Cella, D. F.
    Durie, B. G.
    Kuter, D.
    Moreau, P.
    Bartlett, J. B.
    Kroog, G. S.
    Wagner, S.
    VALUE IN HEALTH, 2012, 15 (04) : A210 - A210
  • [5] Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib
    James C. H. Yang
    Marcia S. Brose
    Gilberto Castro
    Edward S. Kim
    Ulrik N. Lassen
    Serge Leyvraz
    Alberto Pappo
    Fernando López-Ríos
    John A. Reeves
    Marc Fellous
    Frédérique Penault-Llorca
    Erin R. Rudzinski
    Ghazaleh Tabatabai
    Gilles Vassal
    Alexander Drilon
    Jonathan Trent
    BMC Cancer, 22
  • [6] An observational, non-interventional study for the follow-up of patients with amyloidosis who received miridesap followed by dezamizumab in a phase 1 study
    Richards, Duncan
    Millns, Helen
    Cookson, Louise
    Lukas, Mary Ann
    ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [7] An observational, non-interventional study for the follow-up of patients with amyloidosis who received miridesap followed by dezamizumab in a phase 1 study
    Duncan Richards
    Helen Millns
    Louise Cookson
    Mary Ann Lukas
    Orphanet Journal of Rare Diseases, 17
  • [8] Follow-up after acute Pulmonary Embolism. A prospective non-interventional multi-center Cohort Study (FOCUS)
    Konstantinides, Stavros V.
    Lankeit, Mareike
    Wild, Philipp
    Quitzau, Kurt
    Binder, Harald
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 : S20 - S21
  • [9] A Prospective, non-intErventional Registry Study of PatiEnts initiating a Course of drug Therapy for overactIVE bladder (PERSPECTIVE): Rationale, design, and methodology
    Rovner, Eric S.
    Carlson, Kevin, V
    Deal, Anna S.
    Nair, Kavita, V
    Oakkar, Eva E.
    Park, Julie
    Gemmen, Eric
    Kristy, Rita M.
    Gooch, Katherine L.
    Schermer, Carol R.
    CONTEMPORARY CLINICAL TRIALS, 2018, 70 : 83 - 87
  • [10] 2-YEAR FOLLOW-UP OF COPD PATIENTS IN THE NON-INTERVENTIONAL 'REAL-LIFE' DACCORD STUDY IN GERMANY
    Worth, H.
    Buhl, R.
    Criee, C. P.
    Kardos, P.
    Mailaender, C.
    Lossi, N.
    Vogelmeier, C.
    THORAX, 2016, 71 : A159 - A159